Engage Patient Advisory Committees of African American community members with type 2 diabetes in implementing and refining a peer-led medication adherence intervention
This article was originally published here
Pharmacy (Basel). 2022 Mar 10;10(2):37. doi: 10.3390/pharmacy10020037.
African Americans are more likely than non-Hispanic whites to be diagnosed with and die of diabetes. A contributing factor to these health disparities is poor adherence to diabetes medications among African Americans, due in part to sociocultural barriers (e.g., misperceptions about medications and disease), which negatively affect diabetes management. In our previous work, we collaborated with community stakeholders to develop and test an abbreviated version of a culturally appropriate intervention to overcome these barriers to medication adherence. The purpose of this study was to obtain feedback to inform refinement of the comprehensive 8-week intervention. We used a community-based study design to conduct a series of meetings with two patient advisory cohorts of African Americans with type 2 diabetes who were adhering to their diabetes medications (i.e. peer ambassadors). A total of 15 Peer Ambassadors were paired with 21 African American participants (i.e. peers) to provide specific intervention support as peers and serve in an advisory role as a board member. ‘administration. Data was collected during nine board meetings with patient advocates. A qualitative thematic analysis of the data was conducted to synthesize the findings. Feedback from the patient advisory committee helped refine the short-term, short-term, and long-term response. The inclusion of members of the African American community living with type 2 diabetes on the advisory board helped to further tailor the intervention to the specific needs of African Americans with type 2 diabetes in the community.
PMID:35314618 | DOI:10.3390/pharmacy10020037